CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 80 enrolled
Drug / intervention
Sertraline +1 moredrug
Likely dose
Sertraline 25mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04094870
NCT04094870Phase 4Completed
CompareCT.gov

Z 31801 - A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women

University of North Carolina, Chapel Hill·interventional·Posted Sep 19, 2019·Updated Nov 10, 2021

In Brief

A Phase 4 clinical trial evaluating Sertraline and Interpersonal therapy for Perinatal Depression and HIV-1-infection. Completed, enrolled 80 participants across 2 sites.

Detailed Summary

This pilot study will evaluate, through quantitative and qualitative methods, whether different treatments for postpartum depression are feasible and acceptable in postpartum HIV infected women on antiretrovirals (ART). The study will take place at several clinics in Lusaka, Zambia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPerinatal Depression, HIV-1-infection
CountriesZambia
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedSep 19, 2019
Enrollment StartOct 30, 2019
Primary CompletionOct 30, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 6.8 years ago

Interventions

Sertralinedrug

daily SSRI (Sertraline 25mg)

Interpersonal therapybehavioral

11 sessions over a 24-week period